Clinical trial Recruiting at 1 site Interventional Ages 13 to 21

Cooling therapy for mild traumatic brain injury in adolescents

Official title: A Double-Blind, Randomized Study of Clinical Efficacy of Hypothermic Therapy Following Concussion in Adolescent Athletes as Compared to a Sham-Controlled Population

Run by TecTraum Inc. · NCT06929923 · Data updated 2026-11-12

This study is testing if a cooling device can help young athletes aged 12-21 recover better from mild brain injuries they got while playing sports.

More Concussion, Mild trials

Quick facts

Study typeInterventional
Ages13 Years to 21 Years
SexAll
Enrollment66 (estimated)
SponsorTecTraum Inc.
Industry-sponsored
Locations3 sites (Ann Arbor, Michigan and 2 other locations)
StatusRecruiting
StartedFebruary 20, 2025
Main results expectedJune 2027
Study endsJune 2027
Registry record updatedAugust 12, 2026
Trial IDNCT06929923 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adolescents aged 12-21 who have recently been diagnosed with a mild traumatic brain injury from sports activities.

Probably not a fit

Patients who have been cleared to return to play or who have sustained a more serious traumatic brain injury will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the safety and effectiveness of the Pro-2-Cool device, which provides non-invasive cooling to the head and neck, in adolescents aged 12-21 who have sustained a mild traumatic brain injury (mTBI) during sports activities. It is a multi-center, prospective, randomized, non-blinded, dual-arm comparator study enrolling up to 72 patients, with half receiving the cooling treatment and the other half serving as a control group. The goal is to determine if this cooling therapy can improve recovery outcomes for young athletes after mTBI.

Why it matters

Potential benefit: If successful, this approach could lead to improved recovery times and outcomes for adolescents suffering from mild traumatic brain injuries.

How similar studies have gone: While the use of cooling therapies in brain injury is an emerging field, this specific approach using the Pro-2-Cool device has not been extensively tested in prior studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Males and females, 13-21 years of age
2. Confirmed concussion diagnosis consistent with American Congress Rehabilitation Medicine guidelines 21, without any of the following:

   * Glasgow Coma Scale (GCS) score of less than 13 at 30 minutes post-injury
   * Loss of consciousness greater than 30 minutes
   * Post-traumatic amnesia lasting over 24 hours
3. Glasgow Coma Scale (GCS) ≥ 13 at the time of initial injury for study enrollment.
4. Post-Concussion Symptom Scale Score minimum of 15
5. Initial provider visit is within 7 days of injury
6. In generally good health as confirmed by medical history and determined by site investigator or designated trained healthcare professional under the supervision of the principal investigator.
7. Has informed consent obtained per protocol and as required per Institutional Review Board

Exclusion Criteria:

1. Age \< 13 years or \> 21 years
2. Inability to understand the study requirements or provide informed consent
3. Cleared to return to play during initial visit
4. Prior participation in a Pro2Cool Clinical Study
5. Serious traumatic brain injury as evidenced by worsening symptoms:

   * Vomiting \> 2 episodes following injury
   * Seizure
   * Hospitalization
   * Radiology scan indicating brain bleed
   * Slurred speech which has not resolved within 72 hours of concussive injury
6. Physical (e.g., head or neck injury that requires medical treatment) or mental disability hindering adequate response to assessment of symptoms
7. Hemodynamic instability/medical condition requiring further acute life-saving medical intervention
8. History of psychiatric disorder that includes suicide attempts within the last 6 months, unmanaged depression or anxiety, hospitalization for psychiatric treatment within the last 6 months
9. Known brain mass, intracranial hemorrhage, skull fracture
10. Scalp abnormalities including laceration or bleeding
11. Presence of ventriculoperitoneal (VP) shunt
12. Known hematological malignancies, including, but not limited to: multiple myeloma, leukemia, and lymphoma
13. Known history of Reynaud's Disease compromised liver function, cold agglutination, cold sensitivity, cryoglobulinemia, cryofibrinogenemia, and/or a history of severe migraines
14. Known or disclosed pregnancy or breast-feeding
15. Sustains another head or neck injury at the time of concussive injury which requires medical treatment

Where it's running

  • Akron Children's Hospital
    Akron, Ohio, United States
    Recruiting
  • University of Michigan
    Ann Arbor, Michigan, United States
    Not yet recruiting
  • Cleveland Clinic Foundation
    Cleveland, Ohio, United States
    Not yet recruiting

Study contacts

  • Principal investigator: Brian Reilly, MD — Children's Hospital Medical Center of Akron
  • Study coordinator: John Zak, MD, MBA
  • Email: jzak@tectraum.com
  • Phone: 216-789-7676

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.